About Senseonics Holdings, Inc.
https://www.senseonics.comSenseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.
CEO
Timothy T. Goodnow
Compensation Summary
(Year 2022)
Salary $585,999
Bonus $109,000
Stock Awards $2,206,241
Incentive Plan Pay $600,476
All Other Compensation $43,938
Total Compensation $3,545,654
Industry Medical - Devices
Sector Healthcare
Went public December 22, 2015
Method of going public IPO
Full time employees 117
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-10-20 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Total 28
Showing Top 3 of 28
Ratings Snapshot
Rating : C-
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 2
Price To Earnings 1
Price To Book 2
Overall Score 1
Most Recent Analyst Grades
Grade Summary
Buy 2
Overweight 1
Showing Top 3 of 3
Price Target
Target High $1.1
Target Low $1.1
Target Median $1.1
Target Consensus $1.1
Institutional Ownership
Summary
% Of Shares Owned 0.03%
Total Number Of Holders 1
Showing Top 1 of 1
Market Cap $290.86 M
52w High $28.00
52w Low $5.25
P/E -4.69
Volume 577.53K
Outstanding Shares 40.85M
About Senseonics Holdings, Inc.
https://www.senseonics.comSenseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $8.1M ▼ | $23.07M ▲ | $-19.53M ▼ | -241.26% ▼ | $-0.43 ▲ | $-17.98M ▼ |
| Q2-2025 | $8.3M ▲ | $18.22M ▲ | $-15.48M ▼ | -186.53% ▲ | $-0.52 ▼ | $-12.54M ▼ |
| Q1-2025 | $6.26M ▼ | $14.99M ▼ | $-14.26M ▲ | -227.89% ▼ | $-0.4 ▲ | $-12.45M ▲ |
| Q4-2024 | $8.3M ▲ | $18.22M ▼ | $-15.48M ▲ | -186.53% ▲ | $-0.46 ▲ | $-12.54M ▲ |
| Q3-2024 | $4.26M | $18.8M | $-23.98M | -562.42% | $-0.77 | $-21.65M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $111.27M ▼ | $139.92M ▼ | $61.76M ▲ | $78.17M ▼ |
| Q2-2025 | $126.41M ▲ | $150.27M ▲ | $55.55M ▲ | $94.72M ▲ |
| Q1-2025 | $64.24M ▼ | $87.21M ▼ | $52.01M ▼ | $35.2M ▲ |
| Q4-2024 | $74.6M ▲ | $100.44M ▲ | $116.99M ▲ | $-16.55M ▲ |
| Q3-2024 | $74.48M | $96.33M | $113.51M | $-17.18M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-19.53M ▼ | $-15.82M ▼ | $18.89M ▲ | $-134K ▼ | $2.94M ▲ | $-15.98M ▼ |
| Q2-2025 | $-14.5M ▼ | $-9.27M ▲ | $-69.63M ▼ | $71.11M ▲ | $-7.79M ▲ | $-9.39M ▲ |
| Q1-2025 | $-14.26M ▲ | $-16.08M ▼ | $-25.32M ▼ | $6.12M ▼ | $-35.29M ▼ | $-16.51M ▼ |
| Q4-2024 | $-15.48M ▲ | $-14.25M ▲ | $47.67M ▲ | $14.07M ▲ | $47.49M ▲ | $-14.28M ▲ |
| Q3-2024 | $-23.98M | $-14.81M | $3.32M | $3.74M | $-7.75M | $-14.61M |
Revenue by Geography
| Region | Q4-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 NonUS | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $20.00M ▲ | $0 ▼ | $0 ▲ | $10.00M ▲ |
CEO
Timothy T. Goodnow
Compensation Summary
(Year 2022)
Salary $585,999
Bonus $109,000
Stock Awards $2,206,241
Incentive Plan Pay $600,476
All Other Compensation $43,938
Total Compensation $3,545,654
Industry Medical - Devices
Sector Healthcare
Went public December 22, 2015
Method of going public IPO
Full time employees 117
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-10-20 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Total 28
Showing Top 3 of 28
Ratings Snapshot
Rating : C-
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 2
Price To Earnings 1
Price To Book 2
Overall Score 1
Most Recent Analyst Grades
Grade Summary
Buy 2
Overweight 1
Showing Top 3 of 3
Price Target
Target High $1.1
Target Low $1.1
Target Median $1.1
Target Consensus $1.1
Institutional Ownership
Summary
% Of Shares Owned 0.03%
Total Number Of Holders 1
Showing Top 1 of 1